New AI tool detects insulin resistance more accurately than BMI

A new AI tool called AI-IR could revolutionize how doctors evaluate insulin resistance. Developed by researchers at the University of Tokyo Hospital, it leverages routine health data to pinpoint risks more accurately than traditional methods. The study suggests this could help prevent serious diseases, including cancer.

The tool, known as AI-IR, was created by Yuta Hiraike and his team at the University of Tokyo Hospital. Unlike BMI, which offers a broad estimate, AI-IR analyzes nine standard clinical measurements from regular check-ups. This approach makes it both precise and easy to apply in large-scale health screenings.

Insulin resistance is a known risk factor for several cancers, according to the study's findings. By identifying high-risk individuals earlier, AI-IR could support better-targeted prevention and early diagnosis programs. The model's design also means it can be scaled up quickly, offering a practical solution for widespread use.

Despite its potential, no hospitals or medical facilities have yet adopted AI-IR for routine assessments as of February 2026. The tool remains in the research phase, awaiting further validation before real-world implementation.

AI-IR provides a clearer, more accurate way to detect insulin resistance than BMI. Its reliance on existing health data makes it a cost-effective option for large populations. If adopted, the tool could play a key role in reducing cancer risks through earlier and more precise interventions.